Iodixanol

FDA Approved: * May 19, 2022
Pharm Company: * HENGRUI PHARMA
Category: Diagnostic Aid

Iodixanol is an iodine-containing non-ionic radiocontrast agent.[1] It is sold under the trade name Visipaque; it is also sold as a density gradient medium under the name OptiPrep.[2] Visipaque is commonly used as a contrast agent during coronary angiography. It is the only iso-osmolar contrast agent, with an osmolality of 290 mOsm/kg H2O, the same as blood. It is sold in 2 main concentrations 270 mgI/ml and 320 mgI/ml - hence the name Visipaque 270 or 320. ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Visipaque 270 mg/ml Intravascular Injection, Solution
NDC: 0407-2222
Labeler:
Ge Healthcare Inc.
Visipaque 320 mg/ml Intravascular Injection, Solution
NDC: 0407-2223
Labeler:
Ge Healthcare Inc.
Iodixanol 270 mg/ml Intravascular Injection, Solution
NDC: 65219-381
Labeler:
Fresenius Kabi USA, LLC
Iodixanol 320 mg/ml Intravascular Injection, Solution
NDC: 65219-383
Labeler:
Fresenius Kabi USA, LLC